Atlas Trials

The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers

Clinical trial NCT04697654 · COMPLETED

Trial details

NCT number
NCT04697654
Sponsor
Taiwan Liposome Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2020-10-08
Primary completion
2021-06-18
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.